<DOC>
	<DOCNO>NCT01307124</DOCNO>
	<brief_summary>To compare safety efficacy low-dose versus standard dose lopinavir/ritonavir contain HAART regimen virological suppress , HIV RNA viral load &lt; 50 copies/ml 48 week</brief_summary>
	<brief_title>Pediatric Study Appropriate Dose Ritonavir Boosted Lopinavir Thai HIV-infected Children ( PEARL )</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>1 . HIV infection child age &lt; 18 year old 2 . Currently PI regimens 3 . HIV RNA viral load &lt; 50 copies/ml screen 4 . BW 2550 kg 5 . Written inform consent 1 . Relevant history current condition PI resistance , plasma HIV RNA &gt; 1000 copies/ml receive PI regimen least 6 month 2 . On rifampin , nevirapine , efavirenz drug interaction lopinavir 3 . On double boosted protease inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>safety efficacy</keyword>
	<keyword>low dose LPV/r</keyword>
	<keyword>standard dose LPV/r</keyword>
	<keyword>HIV infect child</keyword>
</DOC>